These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Biochemical methods for analysis of histone deacetylases. Kölle D; Brosch G; Lechner T; Lusser A; Loidl P Methods; 1998 Aug; 15(4):323-31. PubMed ID: 9740720 [TBL] [Abstract][Full Text] [Related]
4. HDACs, histone deacetylation and gene transcription: from molecular biology to cancer therapeutics. Gallinari P; Di Marco S; Jones P; Pallaoro M; Steinkühler C Cell Res; 2007 Mar; 17(3):195-211. PubMed ID: 17325692 [TBL] [Abstract][Full Text] [Related]
5. Members of the histone deacetylase superfamily differ in substrate specificity towards small synthetic substrates. Riester D; Wegener D; Hildmann C; Schwienhorst A Biochem Biophys Res Commun; 2004 Nov; 324(3):1116-23. PubMed ID: 15485670 [TBL] [Abstract][Full Text] [Related]
6. Surrogate alcohols and their metabolites modify histone H3 acetylation: involvement of histone acetyl transferase and histone deacetylase. Choudhury M; Shukla SD Alcohol Clin Exp Res; 2008 May; 32(5):829-39. PubMed ID: 18336638 [TBL] [Abstract][Full Text] [Related]
7. NMR profiling of histone deacetylase and acetyl-transferase activities in real time. Dose A; Liokatis S; Theillet FX; Selenko P; Schwarzer D ACS Chem Biol; 2011 May; 6(5):419-24. PubMed ID: 21302972 [TBL] [Abstract][Full Text] [Related]
8. HDAC6 α-tubulin deacetylase: a potential therapeutic target in neurodegenerative diseases. Li G; Jiang H; Chang M; Xie H; Hu L J Neurol Sci; 2011 May; 304(1-2):1-8. PubMed ID: 21377170 [TBL] [Abstract][Full Text] [Related]
11. Histone deacetylases: complex transducers of nuclear signals. Johnson CA; Turner BM Semin Cell Dev Biol; 1999 Apr; 10(2):179-88. PubMed ID: 10441071 [TBL] [Abstract][Full Text] [Related]
12. [Assay for inhibitory activity of histone deacetylase]. Yoshida M Gan To Kagaku Ryoho; 2004 Apr; 31(4):507-11. PubMed ID: 15114691 [TBL] [Abstract][Full Text] [Related]
13. An active site tyrosine residue is essential for amidohydrolase but not for esterase activity of a class 2 histone deacetylase-like bacterial enzyme. Moreth K; Riester D; Hildmann C; Hempel R; Wegener D; Schober A; Schwienhorst A Biochem J; 2007 Feb; 401(3):659-65. PubMed ID: 17037985 [TBL] [Abstract][Full Text] [Related]
14. Factors affecting the substrate specificity of histone deacetylases. Riester D; Hildmann C; Grünewald S; Beckers T; Schwienhorst A Biochem Biophys Res Commun; 2007 Jun; 357(2):439-45. PubMed ID: 17428445 [TBL] [Abstract][Full Text] [Related]
15. HDAC inhibitors for the treatment of cancer. Secrist JP; Zhou X; Richon VM Curr Opin Investig Drugs; 2003 Dec; 4(12):1422-7. PubMed ID: 14763127 [TBL] [Abstract][Full Text] [Related]
16. K-acetylation and its enzymes: overview and new developments. Aka JA; Kim GW; Yang XJ Handb Exp Pharmacol; 2011; 206():1-12. PubMed ID: 21879443 [TBL] [Abstract][Full Text] [Related]
17. Nonradioactive in vitro assays for histone deacetylases. Hauser AT; Gajer Née Wagner JM; Jung M Methods Mol Biol; 2013; 981():211-27. PubMed ID: 23381865 [TBL] [Abstract][Full Text] [Related]
18. NAD+-dependent deacetylation of H4 lysine 16 by class III HDACs. Vaquero A; Sternglanz R; Reinberg D Oncogene; 2007 Aug; 26(37):5505-20. PubMed ID: 17694090 [TBL] [Abstract][Full Text] [Related]